ELWOOD, Kan. – August 20, 2024 – Elanco Animal Health Inc., a global leader in animal health, announced today it plans a $130 million investment through the end of 2026 to expand and renovate its existing manufacturing facility in Elwood, Kansas. The planned expansion in Doniphan County is expected to create approximately 70 new jobs over the next two years.
Elanco’s Elwood site currently manufactures and ships its Canine Parvovirus Monoclonal Antibody (CPMA) and will be the flagship location for Elanco’s future monoclonal antibody manufacturing. This product is the first and only USDA conditionally approved targeted treatment for parvovirus, which affects an estimated 330,000 dogs annually in the U.S. The expansion will add capacity needed to support Elanco’s growth in monoclonal antibody (mAb) innovation.
“The continued investment by Elanco speaks to our state’s pro-business economy,” Governor Laura Kelly said. “Elanco’s expansion not only is creating new job opportunities but adding to the unparalleled economic momentum that has made Kansas the best state in the nation to live, work and raise a family.”
“Expanding the capabilities at our Elwood manufacturing site is a critical step toward executing the most exciting pipeline in Elanco’s 70-year history,” Elanco Manufacturing and Quality Executive Vice President Grace McArdle said. “In partnership with our Elanco R&D colleagues, this site plays a key role in delivering solutions that are transforming the way veterinarians and pet owners care for the world’s animals. We appreciate the commitment of the State of Kansas, Doniphan County and the City of Elwood to help pets live longer, healthier, more active lives.”
The facility expansion will position Elanco to optimally serve customer demands, improving lead times for project development and commercialization. Design-build firm Burns & McDonnell, headquartered in Kansas City, is leading the expansion project as the primary provider of integrated design and construction services.
“Sitting in the heart of the Animal Health Corridor, Kansas is a powerhouse in this critical sector – attracting companies from across the nation and around the world,” Lieutenant Governor and Secretary of Commerce David Toland said. “Elanco is an excellent example of the top-notch employers the Kelly-Toland Administration is committed to partnering with as we grow the state economy.”
With an R&D strategy centered around consistent flow of high-impact innovation in key markets, Elanco is one of only two companies in the animal health industry offering monoclonals on the market today.
"Doniphan County is thrilled to witness the remarkable growth and expansion of Elanco Animal Health in Elwood, Kansas. This achievement underscores the strength and potential of our local economy. Elanco's commitment to innovation and excellence not only brings new jobs and opportunities to our county but also reinforces Elwood's position as a hub for animal health industries. We are proud to support Elanco's ongoing success and look forward to a prosperous future together," said Adrienne Neibling, Economic Development Consultant for Doniphan County.
“Evergy is proud to build on its strong business relationship with Elanco as they expand their northeast Kansas facility,” Chuck Caisley, Evergy Senior Vice President and Chief Customer Officer said. “We are focused on providing affordable, reliable electricity that powers our customers and makes our service area attractive for new and expanding businesses. Elanco is an important part of the growing Animal Health Corridor and a valued Evergy customer.”
The KC region is located in the heart of the Animal Health Corridor, encompassing 56 percent of global animal health, diagnostics and pet food sales. Representing more than 300 animal health companies in the region, the KC Animal Health Corridor, an affiliate of the Kansas City Area Development Council, offers an unparalleled ecosystem for growth and collaboration.
“Elanco Animal Health’s investment in its Kansas facility furthers its commitment of innovation from the center of the global animal health industry,” said Kimberly Young, President of the KC Animal Health Corridor.
About Elanco
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our Elanco Healthy Purpose™ sustainability pillars – all to advance the health of animals, people, the planet and our enterprise. | elanco.com.
About the KC Animal Health Corridor
Representing more than half of the global animal health industry's sales, and home to over 300 animal health companies, the KC Animal Health Corridor is the largest concentration of its kind worldwide. Anchored by Manhattan, Kansas, and Columbia, Missouri, the Corridor serves as a thriving hub for innovation and collaboration. | kcanimalhealth.com.
About the Kansas City Area Development Council (KCADC)
Serving the 18-county, two-state Kansas City area, the Kansas City Area Development Council is an economic development nonprofit that promotes the region’s business and lifestyle assets to companies and talent around the world. Working closely with its two states, and 50-plus county and community partners, the region has attracted more than 64,000 new jobs over its 45-year history. KCADC also leads the efforts behind the KC Animal Health Corridor, KC SmartPort, TeamKC, KC Heartland and KC Global Design. | thinkKC.com